Prestige Consumer Healthcare
242 hedge funds and large institutions have $1.94B invested in Prestige Consumer Healthcare in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 103 reducing their positions, and 37 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.1% less ownership
Funds ownership: 110.53% → 106.43% (-4.1%)
4% less funds holding
Funds holding: 253 → 242 (-11)
7% less capital invested
Capital invested by funds: $2.08B → $1.94B (-$136M)
27% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 37
32% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 103
76% less call options, than puts
Call options by funds: $54K | Put options by funds: $222K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCAM
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
+$20.1M |
| 2 |
Goldman Sachs
New York
|
+$15.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$6.05M |
| 4 |
Man Group
London,
United Kingdom
|
+$4.88M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$14.6M |
| 2 |
JP Morgan Chase
New York
|
-$13.5M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.06M |
| 4 |
BlackRock
New York
|
-$7.88M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.62M |
PBH Hedge Fund Activity: Q3 2020 in Review
242 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2020, worth a combined $1.94B — down 6.5% from $2.08B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of PBH and 27 opened new positions — a net loss of 10 holders — while 103 trimmed existing stakes and 70 added.
The largest buyer was Turtle Creek Asset Management, adding an estimated $20.1M. The largest seller was Nuveen, cutting an estimated $14.6M.
- 242 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2020, down from 253 in Q2 2020.
- Funds reported $1.94B of Prestige Consumer Healthcare stock for Q3 2020, down 6.5% quarter-over-quarter.
- 27 funds opened new Prestige Consumer Healthcare positions in Q3 2020 and 37 closed out, a net change of -10 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2020 was Turtle Creek Asset Management, an estimated $20.1M added.
- The largest Prestige Consumer Healthcare seller in Q3 2020 was Nuveen, an estimated $14.6M sold.
Based on aggregated 13F filings for Q3 2020.